Lexpos News

/Lexpos News

Government announces the next steps for Hub and Spoke dispensing

The Government has laid amendments to the Human Medicines Regulations 2012 (HMR) in Parliament as the next step towards Hub and Spoke dispensing for community pharmacies. The Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025 Key points of the HMR amendments in brief are: Only Model 1: patient – spoke – [...]

The post Government announces the next steps for Hub and Spoke dispensing appeared first on Community Pharmacy England.

By |April 30th, 2025|Lexpos News|Comments Off on Government announces the next steps for Hub and Spoke dispensing

Health Stakeholders briefed on community pharmacy funding settlement

Community Pharmacy England met with health stakeholders last week (Thursday 24th April) to brief them on the impact of the Community Pharmacy Contractual Framework settlement for 2024/25 and 2025/26 on patients and the pharmacy sector. During the event, attendees heard more about the new funding and contractual arrangements, including how the changes will affect community pharmacies, [...]

The post Health Stakeholders briefed on community pharmacy funding settlement appeared first on Community Pharmacy England.

By |April 30th, 2025|Lexpos News|Comments Off on Health Stakeholders briefed on community pharmacy funding settlement

NHSBSA ‘Hints & Tips’ – Issue 59

The NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 58) contains some useful information and advice on: Tax credits ended on Saturday 5 April 2025 NHS Pharmacy First Service – PPV activity MYS January activity – Monday 5 May 2025 deadline Correctly using [...]

The post NHSBSA ‘Hints & Tips’ – Issue 59 appeared first on Community Pharmacy England.

By |April 29th, 2025|Lexpos News|Comments Off on NHSBSA ‘Hints & Tips’ – Issue 59

MHRA Class 4 Medicines Defect Notification: Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg Capsules, (Jubilant Pharmaceuticals NV)

MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd) Drug alert number: EL(25)A/19 Date issued: 29 April 2025 Jubilant Pharmaceuticals BV has informed the Medicines and Health products Regulatory Agency (MHRA) that the outer carton (box) of the product batches mentioned in this notification are missing the medicines legal classification for a Prescription [...]

The post MHRA Class 4 Medicines Defect Notification: Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg Capsules, (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.

By |April 29th, 2025|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg Capsules, (Jubilant Pharmaceuticals NV)

NHS prescription charges frozen for 2025/26

The Department of Health and Social Care (DHSC) has announced that the NHS prescription charge will be kept at £9.90 per prescription item for 2025/26. A Government press release today confirms that the NHS prescription charge will be frozen, as well as the costs for prescription prepayment certificates (PPCs). PPCs offer savings for those needing multiple prescription items or [...]

The post NHS prescription charges frozen for 2025/26 appeared first on Community Pharmacy England.

By |April 28th, 2025|Lexpos News|Comments Off on NHS prescription charges frozen for 2025/26